Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» urothelial cancer
urothelial cancer
Seattle Genetics drug could provide new option for bladder cancer patients
Biopharma Dive
Mon, 06/3/19 - 11:24 am
Seattle Genetics
ASCO 2019
enfortumab vedotin
urothelial cancer
Basilea Enters Collaboration With Roche to Study BAL087 in Combination With Tecentriq in Urothelial Cancer
CP WIre
Thu, 01/24/19 - 11:43 am
Arqule
Basilea
Roche
BAL087
urothelial cancer
Tecentriq
Basilea Enters Collaboration With Roche to Study BAL087 in Combination With Tecentriq in Urothelial Cancer
Thu, 01/24/19 - 10:38 am
Arqule
Basilea
Roche
BAL087
urothelial cancer
Tecentriq
As Barrett steps in as CEO, UroGen reports 57% complete response rate for urothelial cancer therapy
BioCentury
Tue, 01/8/19 - 11:44 pm
Urogen
UGN-101
MitoGel
urothelial cancer
Liz Barrett
Upcoming events – Phase III readouts loom for Urogen and Mediwound
EP Vantage
Fri, 12/21/18 - 12:04 pm
Urogen
clinical trials
UGN-101
urothelial cancer
MediWound
NexoBrid
devices
burns
J&J Files NDA for Erdafitinib in Urothelial Cancer Indication
Yahoo/Zacks.com
Wed, 09/19/18 - 11:52 am
JNJ
erdafitinib
urothelial cancer
Nektar And Bristol Hurtle Forward With Experimental Cancer Drug
Forbes
Sun, 06/3/18 - 10:00 am
Nektar
Bristol-Myers Squibb
NKTR-214
ASCO 2018
melanoma
renal cell carcinoma
urothelial cancer
2013 GU: Dendreon's Neuvenge, A First Look At The Clinical Trial Results
Seeking Alpha
Fri, 02/15/13 - 11:28 am
Dendreon
Neuvenge
urothelial cancer
Pages
« first
‹ previous
1
2